Top

Gepubliceerd in:

03-06-2023

Chronic kidney disease-associated pruritus (CKD-aP) is associated with worse quality of life and increased healthcare utilization among dialysis patients

Auteurs: Jasmine Ion Titapiccolo, Caterina Lonati, Berit Goethel-Paal, Abraham Rincon Bello, Francesco Bellocchio, Alessandro Pizzo, Maxime Theodose, Maria Eva Baro Salvador, Michaela Schofield, Mario Cioffi, Kolitha Basnayake, Chis Chisholm, Suzanne Mitrovic, Marjelka Trkulja, Hans-Juergen Arens, Stefano Stuard, Luca Neri

Gepubliceerd in: Quality of Life Research | Uitgave 10/2023

Abstract

Purpose

Chronic pruritus significantly impairs hemodialysis patients’ health status and quality of life (QOL) and it is associated with higher mortality rate, more frequent hospitalizations, poorer dialysis and medication adherence, and deteriorated mental status. However, pruritus is still underestimated, underdiagnosed, and undertreated in the real-life clinical scenario. We investigated prevalence, clinical characteristics, clinical correlates, severity as well as physical and psychological burden of chronic pruritus among adult hemodialysis patients in a large international real-world cohort.

Methods

We conducted a retrospective cross-sectional study of patients registered in 152 Fresenius Medical Care (FMC) NephroCare clinics located in Italy, France, Ireland, United Kingdom, and Spain. Demographic and medical data were retrieved from the EuCliD® (European Clinical) database, while information on pruritus and QoL were abstracted from KDQOL™-36 and 5-D Itch questionnaire scores.

Results

A total of 6221 patients were included, of which 1238 were from France, 163 Ireland, 1469 Italy, 2633 Spain, and 718 UK. The prevalence of mild-to-severe pruritus was 47.9% (n = 2977 patients). Increased pruritus severity was associated with increased use of antidepressants, antihistamines, and gabapentin. Patients with severe pruritus more likely suffered from diabetes, more frequently missed dialysis sessions, and underwent more hospitalizations due to infections. Both mental and physical QOL scores were progressively lower as the severity of pruritus increased; this association was robust to adjustment for potential confounders.

Conclusion

This international real-world analysis confirms that chronic pruritus is a highly prevalent condition among dialysis patients and highlights its considerable burden on several dimensions of patients’ life.

vorige artikel The differentiating effect of COVID-19-associated stress on the morbidity of blood donors with symptoms of hidradenitis suppurativa, hyperhidrosis, or psoriasis

volgende artikel Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)

Alleen toegankelijk voor geautoriseerde gebruikers

Sukul, N., Karaboyas, A., Csomor, P. A., Schaufler, T., Wen, W., Menzaghi, F., & Pisoni, R. L. (2021). Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients. Kidney Medicine, 3(1), 42–53. https://doi.org/10.1016/j.xkme.2020.08.011CrossRefPubMed

Hu, X., Sang, Y., Yang, M., Chen, X., & Tang, W. (2018). Prevalence of chronic kidney disease-associated pruritus among adult dialysis patients A meta-analysis of cross-sectional studies. Medicine (United States), 97(21), e10633. https://doi.org/10.1097/MD.0000000000010633CrossRef

Verduzco, H. A., & Shirazian, S. (2020). CKD-associated pruritus: New insights into diagnosis, pathogenesis, and management. Kidney International Reports, 5(9), 1387–1402. https://doi.org/10.1016/j.ekir.2020.04.027CrossRefPubMedPubMedCentral

Hashimoto, T., & Yosipovitch, G. (2019). Itching as a systemic disease. Journal of Allergy and Clinical Immunology, 144(2), 375–380. https://doi.org/10.1016/j.jaci.2019.04.005CrossRefPubMed

Manenti, L., & Leuci, E. (2021). Do you feel itchy? A guide towards diagnosis and measurement of chronic kidney disease-associated pruritus in dialysis patients. Clinical Kidney Journal, 14(3), i8–i15. https://doi.org/10.1093/ckj/sfab143CrossRefPubMedPubMedCentral

Kim, D., & Pollock, C. (2021). Epidemiology and burden of chronic kidney disease-associated pruritus. Clinical Kidney Journal, 14(3), i1–i7. https://doi.org/10.1093/ckj/sfab142CrossRefPubMedPubMedCentral

Elhag, S., Rivas, N., Tejovath, S., Mustaffa, N., Deonarine, N., Abdullah Hashmi, M., & Hamid, P. (2022). Chronic kidney disease-associated pruritus: A glance at novel and lesser-known treatments. Cureus, 14(1), 1–11. https://doi.org/10.7759/cureus.21127CrossRef

Świerczyńska, K., Białynicki-Birula, R., & Szepietowski, J. C. (2021). Chronic intractable pruritus in chronic kidney disease patients: Prevalence, impact, and management challenges–a narrative review. Therapeutics and Clinical Risk Management, 17, 1267–1282. https://doi.org/10.2147/TCRM.S310550CrossRefPubMedPubMedCentral

Lipman, Z. M., Paramasivam, V., Yosipovitch, G., & Germain, M. J. (2021). Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches. Clinical Kidney Journal, 14(3), i16–i22. https://doi.org/10.1093/ckj/sfab167CrossRefPubMedPubMedCentral

10.

Kini, S. P., DeLong, L. K., Veledar, E., McKenzie-Brown, A. M., Schaufele, M., & Chen, S. C. (2011). The impact of pruritus on quality of life: The skin equivalent of pain. Archives of Dermatology, 147(10), 1153–1156. https://doi.org/10.1001/archdermatol.2011.178CrossRefPubMed

11.

Pisoni, R. L., Wikström, B., Elder, S. J., Akizawa, T., Asano, Y., Keen, M. L., & Port, F. K. (2006). Pruritus in haemodialysis patients: International results from the dialysis outcomes and practice patterns study (DOPPS). Nephrology Dialysis Transplantation, 21(12), 3495–3505. https://doi.org/10.1093/ndt/gfl461CrossRef

12.

Lopes, G. B., Nogueira, F. C. P., De Souza, M. R., Penalva, M. A., De Amorim, J. L., Pisoni, R. L., & Lopes, A. A. (2012). Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form. Quality of Life Research, 21(4), 603–612. https://doi.org/10.1007/s11136-011-9964-xCrossRefPubMed

13.

Suseł, J., Batycka-Baran, A., Reich, A., & Szepietowski, J. C. (2014). Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Dermato-Venereologica, 94(3), 276–281. https://doi.org/10.2340/00015555-1749CrossRefPubMed

14.

Narita, I., Alchi, B., Omori, K., Sato, F., Ajiro, J., Saga, D., & Gejyo, F. (2006). Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney International, 69(9), 1626–1632. https://doi.org/10.1038/sj.ki.5000251CrossRefPubMed

15.

Rayner, H. C., Larkina, M., Wang, M., Graham-Brown, M., van der Veer, S. N., Ecder, T., & Pisoni, R. L. (2017). International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clinical Journal of the American Society of Nephrology, 12(12), 2000–2007. https://doi.org/10.2215/CJN.03280317CrossRefPubMedPubMedCentral

16.

Shirazian, S., Aina, O., Park, Y., Chowdhury, N., Leger, K., Hou, L., & Mathur, V. S. (2017). Chronic kidney disease-associated pruritus: Impact on quality of life and current management challenges. International Journal of Nephrology and Renovascular Disease, 10, 11–26. https://doi.org/10.2147/IJNRD.S108045CrossRefPubMedPubMedCentral

17.

Kimata, N., Fuller, D. S., Saito, A., Akizawa, T., Fukuhara, S., Pisoni, R. L., & Akiba, T. (2014). Pruritus in hemodialysis patients: Results from the Japanese dialysis outcomes and practice patterns study (JDOPPS). Hemodialysis International, 18(3), 657–667. https://doi.org/10.1111/hdi.12158CrossRefPubMed

18.

Ramakrishnan, K., Bond, T. C., Claxton, A., Sood, V. C., Kootsikas, M., Agnese, W., & Sibbel, S. (2013). Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. International Journal of Nephrology and Renovascular Disease, 7, 1–12. https://doi.org/10.2147/ijnrd.s52985CrossRefPubMedPubMedCentral

19.

Weisshaar, E., Matterne, U., & Mettang, T. (2009). How do nephrologists in haemodialysis units consider the symptom of itch results of a survey in Germany. Nephrology Dialysis Transplantation, 24(4), 1328–1330. https://doi.org/10.1093/ndt/gfn769CrossRef

20.

Aresi, G., Rayner, H. C., Hassan, L., Burton, J. O., Mitra, S., Sanders, C., & van der Veer, S. N. (2019). Reasons for underreporting of uremic pruritus in people with chronic kidney disease: A qualitative study. Journal of Pain and Symptom Management, 58(4), 578-586.e2. https://doi.org/10.1016/j.jpainsymman.2019.06.010CrossRefPubMed

21.

Marcelli, D. (2001). EuCliD (European Clinical Database): A database comparing different realities. Journal of Nephrology, 14, S94–S100.PubMed

22.

Garbelli, M., Ion Titapiccolo, J., Bellocchio, F., Stuard, S., Brancaccio, D., & Neri, L. (2022). Prolonged patient survival after implementation of a continuous quality improvement programme empowered by digital transformation in a large dialysis network. Nephrology Dialysis Transplantation, 37(3), 469–476. https://doi.org/10.1093/ndt/gfab160CrossRef

23.

Pizzarelli, F., & Basile, C. (2022). Do we have to rely on metric-based quality improvement strategies for the management of ESKD? Nephrology, dialysis, transplantation : Official publication of the European Dialysis and Transplant Association - European Renal Association, 37(3), 397–399. https://doi.org/10.1093/NDT/GFAB201CrossRefPubMed

24.

Viecelli, A. K., Tong, A., O’Lone, E., Ju, A., Hanson, C. S., Sautenet, B., & Ennis, D. (2018). Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop on establishing a core outcome measure for hemodialysis vascular access. American Journal of Kidney Diseases, 71(5), 690–700. https://doi.org/10.1053/j.ajkd.2017.12.003CrossRefPubMed

25.

Bellocchio, F., Carioni, P., Lonati, C., Garbelli, M., Martínez-Martínez, F., Stuard, S., & Neri, L. (2021). Enhanced sentinel surveillance system for covid-19 outbreak prediction in a large european dialysis clinics network. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph18189739CrossRefPubMedPubMedCentral

26.

Bellocchio, F., Lonati, C., Titapiccolo, J. I., Nadal, J., Meiselbach, H., Schmid, M., & Neri, L. (2021). Validation of a novel predictive algorithm for kidney failure in patients suffering from chronic kidney disease: The prognostic reasoning system for chronic kidney disease (PROGRES-CKD). International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph182312649CrossRefPubMedPubMedCentral

27.

Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., & Carter, W. B. (1994). Development of the kidney disease quality of life (KDQOLTM) instrument. Quality of Life Research, 3(5), 329–338. https://doi.org/10.1007/BF00451725CrossRefPubMed

28.

Elman, S., Hynan, L. S., Gabriel, V., & Mayo, M. J. (2010). The 5-D itch scale: A new measure of pruritus. British Journal of Dermatology, 162(3), 587–593. https://doi.org/10.1111/j.1365-2133.2009.09586.xCrossRefPubMed

29.

Lai, J. W., Chen, H. C., Chou, C. Y., Yen, H. R., Li, T. C., Sun, M. F., & Chang, C. T. (2017). Transformation of 5-D itch scale and numerical rating scale in chronic hemodialysis patients. BMC Nephrology, 18(1), 1–5. https://doi.org/10.1186/s12882-017-0475-zCrossRef

30.

Cheung, H. N., Chan, Y. S., & Hsiung, N. H. (2021). Validation of the 5-D Itch scale in three ethnic groups and exploring optimal cutoff values using the Itch numerical rating scale. BioMed Research International. https://doi.org/10.1155/2021/7640314CrossRefPubMedPubMedCentral

31.

Peipert, J. D., Nair, D., Klicko, K., Schatell, D. R., Hays, R. D., & A., T., … Pollock, C. (2021). Kidney disease quality of life 36-item short form survey (KDQOL-36) normative values for the United States dialysis population and new single summary score. Clinical Kidney Journal, 14(3), i16–i22. https://doi.org/10.1093/ckj/sfab142CrossRef

32.

Leyland, A. H., & Groenewegen, P. P. (2020). Apportioning variation in multilevel models. Multilevel Modelling for Public Health and Health Services Research. https://doi.org/10.1007/978-3-030-34801-4_6CrossRef

33.

Leyland, A. H., & Groenewegen, P. P. (2020). Multilevel modelling for public health and health services research. Multilevel Modelling for Public Health and Health Services Research. https://doi.org/10.1007/978-3-030-34801-4CrossRef

34.

Goldstein, H., Browne, W., & Rasbash, J. (2010). Partitioning variation in multilevel models. Understanding Statistics, 1(4), 223–231.CrossRef

35.

Sukul, N., Speyer, E., Tu, C., Bieber, B. A., Li, Y., Lopes, A. A., & Pisoni, R. L. (2019). Pruritus and patient reported outcomes in non-dialysis CKD. Clinical Journal of the American Society of Nephrology, 7(14), 673–681. https://doi.org/10.2215/CJN.09600818CrossRef

36.

Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the health utilities index mark II. PharmacoEconomics, 15(2), 141–155. https://doi.org/10.2165/00019053-199915020-00003CrossRefPubMed

37.

Feldman, R., Berman, N., Reid, M. C., Roberts, J., Shengelia, R., Christianer, K., & Adelman, R. D. (2013). Improving symptom management in hemodialysis patients: Identifying barriers and future directions. Journal of Palliative Medicine, 16(12), 1528–1533. https://doi.org/10.1089/jpm.2013.0176CrossRefPubMedPubMedCentral

38.

Manns, B., Hemmelgarn, B., Lillie, E., Dip, S. C. P. G., Cyr, A., Gladish, M., & Laupacis, A. (2014). Setting research priorities for patients on or nearing dialysis. Clinical Journal of the American Society of Nephrology, 9(10), 1813–1821. https://doi.org/10.2215/CJN.01610214CrossRefPubMedPubMedCentral

39.

Weiss, M., Mettang, T., Tschulena, U., Passlick-Deetjen, J., & Weisshaar, E. (2015). Prevalence of chronic itch and associated factors in haemodialysis patients: A representative cross-sectional study. Acta Dermato-Venereologica, 95(7), 816–821. https://doi.org/10.2340/00015555-2087CrossRefPubMed

40.

Yamamoto, Y., Hayashino, Y., Yamazaki, S., Akiba, T., Akizawa, T., Asano, Y., & Fukuhara, S. (2009). Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan dialysis outcomes and practice patterns study. British Journal of Dermatology, 161(2), 384–389. https://doi.org/10.1111/j.1365-2133.2009.09088.xCrossRefPubMed

41.

Einollahi, B., Motalebi, M., & Izadianmehr, N. (2014). Re: Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients. Iranian Journal of Kidney Diseases, 8(3), 257–258.PubMed

42.

Weisshaar, E., Weiss, M., Passlick-Deetjen, J., Tschulena, U., Maleki, K., & Mettang, T. (2015). Laboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch - Results from a representative cross-sectional study. BMC Nephrology, 16(1), 1–8. https://doi.org/10.1186/s12882-015-0177-3CrossRef

43.

Shirazian, S., Kline, M., Sakhiya, V., Schanler, M., Moledina, D., Patel, C., & Fishbane, S. (2013). Longitudinal predictors of uremic pruritus. Journal of Renal Nutrition, 23(6), 428–431. https://doi.org/10.1053/j.jrn.2013.08.002CrossRefPubMed

44.

Khanna, D., Singal, A., & Kalra, O. P. (2010). Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgraduate Medical Journal, 86(1021), 641–647. https://doi.org/10.1136/pgmj.2009.095745CrossRefPubMed

45.

Ko, M. J., Wu, H. Y., Chen, H. Y., Chiu, Y. L., Hsu, S. P., Pai, M. F., & Jee, S. H. (2013). Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: A prospective 5-year cohort study. PLoS ONE, 8(8), e71404. https://doi.org/10.1371/journal.pone.0071404CrossRefPubMedPubMedCentral

46.

Mathur, V. S., Kumar, J., Crawford, P. W., Hait, H., Sciascia, T., Kumagai, H., & Suzuki, H. (2018). Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: A Phase III, randomized, double-blind, placebo-controlled study. Nephrology Dialysis Transplantation, 25(4), 1251–1257. https://doi.org/10.1159/000484573CrossRef

47.

Kumagai, H., Ebata, T., Takamori, K., Muramatsu, T., Nakamoto, H., & Suzuki, H. (2010). Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: A Phase III, randomized, double-blind, placebo-controlled study. Nephrology Dialysis Transplantation, 25(4), 1251–1257. https://doi.org/10.1093/ndt/gfp588CrossRef

48.

Fishbane, S., Jamal, A., Munera, C., Wen, W., & Menzaghi, F. (2020). A Phase 3 trial of Difelikefalin in hemodialysis patients with pruritus. New England Journal of Medicine, 382(3), 222–232. https://doi.org/10.1056/nejmoa1912770CrossRefPubMed

Titel: Chronic kidney disease-associated pruritus (CKD-aP) is associated with worse quality of life and increased healthcare utilization among dialysis patients
Auteurs: Jasmine Ion Titapiccolo
Caterina Lonati
Berit Goethel-Paal
Abraham Rincon Bello
Francesco Bellocchio
Alessandro Pizzo
Maxime Theodose
Maria Eva Baro Salvador
Michaela Schofield
Mario Cioffi
Kolitha Basnayake
Chis Chisholm
Suzanne Mitrovic
Marjelka Trkulja
Hans-Juergen Arens
Stefano Stuard
Luca Neri
Publicatiedatum: 03-06-2023
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 10/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-023-03438-6

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 10/2023

GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): psychometric properties and clinically meaningful thresholds as assessed in the Phase 3 DeFi randomized controlled clinical trial

Enabling QALY estimation in mental health trials and care settings: mapping from the PHQ-9 and GAD-7 to the ReQoL-UI or EQ-5D-5L using mixture models

Measuring PROMIS pain interference in German patients with chronic conditions: calibration, validation, and cross-cultural use of item parameters

The structure of well-being: a single underlying factor with genetic and environmental influences

The use of PROMIS measures in clinical studies in patients with inflammatory arthritis: a systematic review

Dutch normative data of the sexual distress scale and the body image scale